Skip to content

Depression: all studies

Page 991 of 1,036: studies 9,901 to 9,910 of 10,358, newest first. Back to the depression overview

Research

Validity and reliability of the Structured Clinical Interview for Depersonalization-Derealization Spectrum (SCI-DER).

Neuropsychiatric Disease and Treatment October 1, 2008 Marco Mula, Stefano Pini, Simona Calugi et al.

This study evaluates the validity and reliability of a new instrument developed to assess symptoms of depresonalization: the Structured Clinical Interview for the Depersonalization-Derealization Spectrum (SCI-DER). The instrument is based on a spectrum model that emphasizes soft-signs, sub-threshold syndromes as well as clinical and subsyndromal manifestations. Items of the interview include,...

DOI: 10.2147/ndt.s3622 (opens in new tab) Full text (opens in new tab) Mood disorders Anxiety disorders Depersonalization Derealization

Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates.

Neuropsychopharmacology October 2008 Tiziana Rubino, Daniela Vigano', Natalia Realini et al.

Few and often contradictory reports exist on the long-term neurobiological consequences of cannabinoid consumption in adolescents. The endocannabinoid system plays an important role during the different stages of brain development as cannabinoids influence the release and action of different neurotransmitters and promote neurogenesis. This study tested whether long-lasting interference by...

Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats.

Neuropsychopharmacology October 2008 Elena H Chartoff, David Potter, Diane Damez-Werno et al.

Stress and chronic exposure to drugs of abuse can trigger addictive and depressive disorders. Both stimuli increase activity of dynorphin, a neuropeptide that acts at kappa-opioid receptors (KORs). In humans, KOR agonists cause dysphoria, raising the possibility that dynorphin modulates the depressive-like effects of stress and chronic drug use. We examined if KOR activation alters sensitivity...

Development and Characterization of a Novel Animal Model of Intermittent MDMA (“Ecstasy”) Exposure during Adolescence

Annals of the New York Academy of Sciences October 1, 2008 Jerrold S. Meyer, Brian J. Piper, Valerie E. Vancollie 44 citations

Adult animals treated with high doses of MDMA (“ecstasy”) either on a single day or for several consecutive days show numerous behavioral changes as well as persistent reductions in brain serotonin (5‐HT) concentrations and 5‐HT transporter (SERT) protein expression. However, such dosing regimens do not adequately mimic the intermittent use patterns commonly seen in adolescent recreational...

DOI: 10.1196/annals.1432.029 (opens in new tab) MDMA Ecstasy Hallucinogen Serotonin transporter +3

Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 days.

The International Journal of Neuropsychopharmacology September 2008 Eszter Kirilly, Eszter Molnár, Brigitta Balogh et al.

The recreational drug ecstasy [3,4-methylenedioxymethamphetamine (MDMA)], has been found to selectively damage brain serotonin neurons in experimental animals, and probably in human MDMA users, but detailed morphometric analyses and parallel functional measures during damage and recovery are missing. Since there is evidence that serotonin regulates sleep, we have compared serotonergic markers...

Liquid ecstasy - a significant drug problem.

Deutsches Ärzteblatt international September 2008 Hilke Andresen, Thomas Stimpfl, Nadine Sprys et al.

Gamma-hydroxybutyric acid (GHB, "liquid ecstasy") and its legal pro-drugs gamma-butyrolactone and 1,4-butanediol are gaining in importance as recreational drugs in Germany. The effects of these substances are comparable with those of alcohol or benzodiazepines. Because of the wide availability of GHB physicians are increasingly being confronted with cases of intoxication. This review is based...

Mindfulness-based stress reduction training for oncology patients: patients' appraisal and changes in well-being.

Patient education and counseling September 2008 Arenda Kieviet-Stijnen, Adriaan Visser, Bert Garssen et al.

This study explores satisfaction and changes in well-being in cancer patients following mindfulness-based stress reduction training. Data were collected in 47 cancer patients before and after the training, and also 1 year later. Standardized questionnaires were used to measure quality of life, joy in life, mood disturbances (depression, anger, vigor, fatigue, and tension), meaning in life and...

5-HT2A/2C receptor blockade regulates progenitor cell proliferation in the adult rat hippocampus.

Neuroscience Letters August 22, 2008 Shanker Jha, Rajeev Rajendran, Kimberly A Fernandes et al.

Adult hippocampal neurogenesis is reported to be a target of antidepressants, drugs of abuse and animal models of depression, suggesting a role for this form of structural plasticity in psychopathology. Serotonergic neurotransmission, which is implicated in several psychiatric diseases, has been reported to regulate adult hippocampal neurogenesis. Amongst the serotonergic receptors, the...

Mindfulness-Based Cognitive Therapy

August 18, 2008 Rebecca S. Crane 90 citations

Mindfulness-Based Cognitive Therapy (MBCT) is increasingly used in therapeutic practice. It encourages clients to process experience without judgement as it arises, helping them to change their relationship with challenging thoughts and feelings, and accept that, even though difficult things may happen, it is possible to work with these in new ways. This book provides a basis for understanding...

DOI: 10.4324/9780203882344 (opens in new tab) Psychotherapist Mindfulness-based cognitive therapy Cognition

[Neuropsychopharmacology of delta-9-tetrahydrocannabinol].

Annales pharmaceutiques francaises August 2008 J Costentin

Today, the main route of introduction of tetrahydrocannabinol (THC), the main active substance of cannabis, into the human body is via the lungs, from smokes produced by combustion of a haschich-tobacco mixture. The use of a water pipe (nargileh-like) intensifies its fast supply to the body. THC reaches the brain easily where it stimulates CB1 receptors; their ubiquity underlies a wide variety...